What is the appropriate intravenous phenytoin (Epsolin) loading and maintenance dose for a 25‑kg child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Phenytoin (Epsolin) Dosing for a 25 kg Child

For a 25 kg child, administer a loading dose of 500 mg (20 mg/kg) of intravenous phenytoin infused over 10–20 minutes, not exceeding 1 mg/kg/min (25 mg/min for this child), followed by maintenance dosing of 5 mg/kg/day divided into two doses starting 12–24 hours after the loading dose. 1

Loading Dose Administration

  • The standard loading dose is 20 mg/kg intravenously, which equals 500 mg for a 25 kg child 1
  • Infuse over 10–20 minutes with a maximum infusion rate of 1 mg/kg/min (not exceeding 25 mg/min for this child) 1
  • If fosphenytoin is available, it is preferred because it has a lower risk of adverse cardiac effects and can be infused more rapidly (up to 2 mg PE/kg/min or 50 mg PE/min for this child) 1, 2

Critical Administration Requirements

  • Dilute phenytoin only in normal saline to avoid precipitation; it is incompatible with glucose-containing solutions 1
  • Monitor heart rate continuously during infusion and reduce the infusion rate if heart rate decreases by 10 beats per minute 1
  • Be prepared to provide respiratory support, as there is an increased incidence of apnea when combined with other sedative agents 1
  • Monitor oxygen saturation throughout the infusion 1

Maintenance Dosing

  • Start maintenance therapy at 5 mg/kg/day (125 mg/day for a 25 kg child), typically divided into two doses 3
  • Begin maintenance dosing 12–24 hours after the loading dose 1
  • Adjust subsequent doses based on clinical response and serum phenytoin levels 3

Monitoring Parameters

  • Obtain serum phenytoin level 1–3 hours after completion of the loading dose to confirm therapeutic range (10–20 mcg/mL) 4, 5
  • Therapeutic levels should be achieved within 30 minutes of completing the infusion in most patients 1
  • Continue cardiac monitoring for hypotension and arrhythmias, especially with rapid infusion 1, 2

Important Safety Considerations

Cardiovascular Risks

  • Phenytoin may cause hypotension and arrhythmias, particularly with rapid infusion 1
  • Continuous heart rate monitoring is mandatory; slow or stop the infusion if bradycardia develops 1, 2

Repeat Dosing if Needed

  • A second loading dose of 10 mg/kg (250 mg) may be given 15 minutes after the initial dose if seizures persist, with a maximum total loading dose of 30 mg/kg (750 mg for this child) 1
  • Reassess clinical response and serum levels before administering additional doses 4

Weight-Based Dosing Accuracy

  • Use actual measured weight whenever possible rather than estimated weight, as estimation errors can result in doses ranging from 78% to 138% of the intended dose 4
  • In this cohort, 20% of children achieved supra-therapeutic levels (>20 mcg/mL) with the 20 mg/kg loading dose, with three experiencing adverse effects consistent with phenytoin toxicity 4

Common Pitfalls to Avoid

  • Never mix phenytoin with dextrose-containing solutions, as this causes immediate precipitation 1, 2
  • Do not infuse faster than 1 mg/kg/min (25 mg/min for a 25 kg child) to minimize cardiovascular complications 1
  • Avoid using phenytoin in neonates when possible, as they have increased risk of toxicity due to decreased protein binding; phenobarbital is preferred in this age group 1
  • Do not assume therapeutic levels will persist beyond 24 hours without maintenance dosing, as phenytoin has complex pharmacokinetics in children 4, 6

References

Related Questions

What is the normal dose of Phenytoin?
What is the drop per minute rate for administering Phenytoin to a 7kg boy, given 15mg/kg in 50ml NS over 15 minutes?
What is the dose and drop rate of Phenytoin (antiepileptic medication) for a 7kg boy when administered in 100ml of normal saline (NS) over 30 minutes?
What is the dose and drip rate of Phenytoin (antiepileptic medication) in 100 ml of Normal Saline (NS) for a patient?
What is the recommended loading dose of Dilantin (Phenytoin) for an 11kg child?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and the International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing bulimia nervosa?
In a 5‑year‑old boy with leukocyturia, bacteriuria, mild hyperbilirubinemia, elevated serum iron, reduced prothrombin activity (INR 1.24), neurobehavioral deficits (slow reaction, poor memory, fear of heights, sleeve‑chewing), frequent urination, a perianal protrusion, and a neck swelling that enlarges with Valsalva, what is the differential diagnosis and which investigations are indicated?
When should isoniazid, rifampicin, and pyrazinamide be stopped in a patient with suspected anti‑tuberculosis drug‑induced hepatotoxicity, based on alanine aminotransferase, aspartate aminotransferase, bilirubin, INR levels, or clinical signs of acute liver failure?
What is the recommended pre‑operative intravenous nalbuphine dose (mg per kilogram) for an adult patient undergoing surgery?
What are the diagnostic changes for Binge‑Eating Disorder across the Diagnostic and Statistical Manual of Mental Disorders (DSM) versions III, III‑TR (Text Revision), IV, V, and V‑TR (Text Revision), and the International Classification of Diseases (ICD) versions X and XI?
What is the recommended diagnostic workup and treatment—including surgery, albendazole dosing, percutaneous aspiration, injection, and re‑aspiration (PAIR), and follow‑up—for a patient with a hydatid cyst?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.